Masaru Matsuda sold $32K of Arcutis Biotherapeutics, Inc. (ARQT) stock

Masaru Matsuda sold 1,230 shares of ARQT stock worth $32K, per an SEC Form 4 filed Aug 6, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 3, 2026, 3 days before it was made public.

ARQT has moved +0.1% since the trade date, from $25.94 to $25.96 (Sep 21, 2026 close).